Novo Says May Take Years to Comply With FDA Request

Feb. 11 (Bloomberg) -- Novo Nordisk A/S Chief Executive Officer Lars Rebien Soerensen discusses the U.S. Food and Drug Administration's decision not to approve the insulin maker's Tresiba diabetes treatment, saying more data on heart safety is needed. He talks from Copenhagen with Francine Lacqua on Bloomberg Television's "On the Move." (Source: Bloomberg)

Good Fortunes: Alejandro Legorreta
49:58 - Alejandro Legorreta is putting his success in finance to work in his native Mexico. His social conscious saw him co-found the Legorreta Hernandez Foundation, a non-profit organization that works directly with disadvantaged communities.
  • Good Fortunes: Roshni Nadar
  • Happy Birthday Shanghai Stock Exchange!
  • Is Doing Business With Russia Ever Easy?